Validation of Microarray for the Simultaneous Detection of Common α- and β-Thalassemia Gene Mutations

Lab Med. 2019 Jul 16;50(3):306-312. doi: 10.1093/labmed/lmy087.

Abstract

Background: Methods for detecting the complex genetic characteristics of α- and β-thalassemias are required for preventing and controlling the outbreak of new cases.

Methods: We evaluated the accuracy and practical utility of microarray for simultaneous detection of α- and β-thalassemias. A total of 102 DNA specimens, which represented 25 different genotypes, were tested in parallel using the microarray and reference methods used in the thalassemia laboratory of the Associated Medical Sciences-Clinical Services Center (AMS-CSC), Chiang Mai, Thailand.

Results: A total of 100 (98.0%) DNA specimens were completely concordant between the microarray and reference methods, whereas discrepancies between the different methods were observed in only 2 DNA specimens with homozygous hemoglobin E (HbE).

Conclusions: The microarray appeared to be a fast, easy to perform, and accurate method for simultaneous detection of α- and β-thalassemias in Thailand and Southeast Asian countries. However, this technique needs to be improved and validated in a larger number of specimens with homozygous HbE before further routine laboratory use.

Keywords: capillary electrophoresis; detection; microarray; thalassemia.

Publication types

  • Validation Study

MeSH terms

  • Genotype
  • Genotyping Techniques / methods*
  • Humans
  • Microarray Analysis / methods*
  • Molecular Diagnostic Techniques / methods*
  • Mutation
  • Thailand
  • alpha-Thalassemia / diagnosis*
  • beta-Thalassemia / diagnosis*